<SEC-DOCUMENT>0001206774-18-000173.txt : 20180122
<SEC-HEADER>0001206774-18-000173.hdr.sgml : 20180122
<ACCEPTANCE-DATETIME>20180122163042
ACCESSION NUMBER:		0001206774-18-000173
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		3
CONFORMED PERIOD OF REPORT:	20180117
ITEM INFORMATION:		Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20180122
DATE AS OF CHANGE:		20180122

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			CLOROX CO /DE/
		CENTRAL INDEX KEY:			0000021076
		STANDARD INDUSTRIAL CLASSIFICATION:	SPECIALTY CLEANING, POLISHING AND SANITATION PREPARATIONS [2842]
		IRS NUMBER:				310595760
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			0630

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-07151
		FILM NUMBER:		18540139

	BUSINESS ADDRESS:	
		STREET 1:		THE CLOROX COMPANY
		STREET 2:		1221 BROADWAY
		CITY:			OAKLAND
		STATE:			CA
		ZIP:			94612-1888
		BUSINESS PHONE:		5102717000

	MAIL ADDRESS:	
		STREET 1:		P.O. BOX 24305
		CITY:			OAKLAND
		STATE:			CA
		ZIP:			94612-1305
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>clorox3371771-8k.htm
<DESCRIPTION>CURRENT REPORT
<TEXT>

<HTML>
<HEAD>
   <TITLE></TITLE>
</HEAD>

<BODY bgcolor="#ffffff">




<HR style="height: 1px; margin-top: 12pt" color=black>

<HR style="MARGIN-TOP: 7px; height: 1px" color=black >


<P style="TEXT-ALIGN: center"><B><FONT style="FONT-SIZE: 16pt" face="Times New Roman">UNITED STATES<BR></FONT></B><B><FONT style="FONT-SIZE: 16pt" face="Times New Roman">SECURITIES AND EXCHANGE
COMMISSION<BR></FONT></B><B><FONT face="Times New Roman" size=2>Washington, D.C.
20549<BR>___________________</FONT></B></P>
<P style="TEXT-ALIGN: center"><B><FONT style="FONT-SIZE: 16pt" face="Times New Roman">FORM 8-K</FONT></B></P>
<P style="TEXT-ALIGN: center"><FONT face="Times New Roman" size=2>CURRENT
REPORT<BR></FONT><FONT face="Times New Roman" size=2>Pursuant to Section 13 OR
15(d) of the Securities Exchange Act of 1934</FONT></P>
<P style="TEXT-ALIGN: center"><FONT face="Times New Roman" size=2>Date of Report
(Date of earliest event reported): January 17, 2018</FONT></P>
<P style="TEXT-ALIGN: center"><FONT style="FONT-SIZE: 16pt" face="Times New Roman">THE CLOROX COMPANY<BR></FONT><FONT face="Times New Roman" size=2>(Exact name of registrant as specified in its charter)</FONT></P>
<DIV align=center>___________________</DIV><BR>
<TABLE style="LINE-HEIGHT: 14pt" cellSpacing=0 cellPadding=0 width="100%" border=0>

  <TR vAlign=bottom>
    <TD noWrap style="text-align: center" width="33%"><FONT face="Times New Roman" size=3>Delaware</FONT></TD>
    <TD noWrap style="text-align: center" width="33%"><FONT face="Times New Roman" size=3>1-07151</FONT></TD>
    <TD noWrap style="text-align: center" width="33%"><FONT face="Times New Roman" size=3>31-0595760</FONT></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap style="text-align: center" width="33%"><FONT face="Times New Roman" size=2>(State or other jurisdiction of</FONT></TD>
    <TD noWrap style="text-align: center" width="33%"><FONT face="Times New Roman" size=2>(Commission File Number)</FONT></TD>
    <TD noWrap style="text-align: center" width="33%"><FONT face="Times New Roman" size=2>(I.R.S. Employer</FONT></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap style="text-align: center" width="33%"><FONT face="Times New Roman" size=2>incorporation)</FONT></TD>
    <TD noWrap align=left width="33%"></TD>
    <TD noWrap style="text-align: center" width="33%"><FONT face="Times New Roman" size=2>Identification No.)</FONT></TD></TR></TABLE>
<P style="TEXT-ALIGN: center"><B><FONT face="Times New Roman" size=2>1221
Broadway, Oakland, California 94612-1888<BR></FONT></B><FONT face="Times New Roman" size=2>(Address of principal executive offices) (Zip
code)</FONT></P>
<P style="TEXT-ALIGN: center"><B><FONT face="Times New Roman" size=2>(510)
271-7000<BR></FONT></B><FONT face="Times New Roman" size=2>(Registrant's
telephone number, including area code)</FONT></P>
<P style="TEXT-ALIGN: center"><B><FONT face="Times New Roman" size=2>Not
applicable<BR></FONT></B><FONT face="Times New Roman" size=2>(Former name or
former address, if changed since last report)</FONT></P>
<P style="TEXT-ALIGN: left"><FONT face="Times New Roman" size=2>Check the
appropriate box below if the Form 8-K filing is intended to simultaneously
satisfy the filing obligation of the registrant under any of the following
provisions:</FONT></P>
<P style="TEXT-ALIGN: left"><FONT face="Times New Roman" size=2>[ ] Written
communications pursuant to Rule 425 Under the Securities Act (17 CFR
230.425)</FONT></P>
<P style="TEXT-ALIGN: left"><FONT face="Times New Roman" size=2>[ ] Soliciting
material pursuant to Rule 14a-12 under the Exchange Act (17 CFR
240.14a-12)</FONT></P>
<P style="TEXT-ALIGN: left"><FONT face="Times New Roman" size=2>[ ]
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act
(17 CFR 240.14d-2(b))</FONT></P>
<P style="TEXT-ALIGN: left"><FONT face="Times New Roman" size=2>[ ]
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act
(17 CFR 240.13e-4(c))</FONT></P>
<P style="TEXT-ALIGN: left"><FONT face="Times New Roman" size=2>Indicate by
check mark whether the registrant is an emerging growth company as defined in
Rule 405 of the Securities Act of 1933 (17 CFR 230.405) or Rule 12b-2 of the
Securities Exchange Act of 1934 (17 CFR 240.12b-2).</FONT></P>
<P style="TEXT-ALIGN: left"><FONT face="Times New Roman" size=2>Emerging growth
company &#9744; </FONT></P>
<P style="TEXT-ALIGN: left"><FONT face="Times New Roman" size=2>If an emerging
growth company, indicate by check mark if the registrant has elected not to use
the extended transition period for complying with any new or revised financial
accounting standards provided pursuant to Section 13(a) of the Exchange Act. &#9744;
</FONT></P>
<HR style="margin-bottom: 12pt" align=center width="100%" color=black SIZE=1>

<BR>

<HR noshade align="center" width="100%" size=2>

<DIV STYLE="page-break-before: always"></DIV>



<TABLE cellSpacing=0 cellPadding=0 width="100%" border=0>

<TR vAlign=bottom>
   <TD NOWRAP STYLE="width: 1%; text-align: left; vertical-align: top"><B><FONT size=2 face="Times New Roman"><B><FONT size=2 face="Times New Roman">Item 5.02&nbsp;</FONT></B></FONT></B></TD>
   <TD STYLE="width: 100%; text-align: left"><B><FONT size=2 face="Times New Roman">Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.</FONT></B></TD></TR></TABLE>

<P style="TEXT-ALIGN: left"><FONT size=2 face="Times New Roman">(b) and (e) On January 17, 2018, Stephen M. Robb, Executive Vice President &#8211; Chief Financial Officer of The Clorox Company (the &#8220;Company&#8221;), provided notice of his intention to retire from the Company on March 31, 2018, following 29 years of service with the Company. Mr. Robb will continue in an advisory capacity through the end of the fiscal year.</FONT></P>
<P style="TEXT-ALIGN: left"><FONT size=2 face="Times New Roman">(c) On January 17, 2018, the Board of Directors (the &#8220;Board&#8221;) of the Company appointed Kevin Jacobsen, age 51, to be Senior Vice President &#8211; Chief Financial Officer, effective April 1, 2018.</FONT></P>
<P style="TEXT-ALIGN: left"><FONT size=2 face="Times New Roman">Mr. Jacobsen is currently the Company&#8217;s Vice President &#8211; Financial Planning &amp; Analysis, a position he has held since November 2011. In this role, he is responsible for providing leadership for financial planning and analysis across all of the Company&#8217;s existing businesses and for its business development efforts. Mr. Jacobsen joined the Company in 1995 and has held a number of senior leadership roles in the Company&#8217;s finance department over the years, including serving as the finance leader for the Specialty Division, the Product Supply Organization and various business units.</FONT></P>
<P style="TEXT-ALIGN: left"><FONT size=2 face="Times New Roman">In connection with Mr. Jacobsen&#8217;s appointment, on January 19, 2018, the Management Development and Compensation Committee of the Board approved an increase in Mr. Jacobsen&#8217;s base salary to $500,000 and an increase in his short-term incentive target from 50% to 80% of his salary, effective as of April 1, 2018. In addition, on April 2, 2018, Mr. Jacobsen will receive stock options that have an aggregate fair value of $200,000, which will vest over four years, and performance shares with an aggregate target fair value of $200,000.</FONT></P>
<P style="TEXT-ALIGN: left"><FONT size=2 face="Times New Roman">A copy of the press release announcing the future Chief Financial Officer changes is filed as Exhibit 99.1 hereto and is incorporated herein by reference.</FONT></P>
<P style="TEXT-ALIGN: left"><B><FONT size=2 face="Times New Roman">Item 9.01 Financial Statements and Exhibits</FONT></B></P>
<P style="TEXT-ALIGN: left"><B><FONT size=2 face="Times New Roman">(d) Exhibits.</FONT></B></P>
<P style="TEXT-ALIGN: left"><FONT size=2 face="Times New Roman">See the Exhibit Index below.</FONT></P>
<P style="TEXT-ALIGN: center"><B><FONT size=2 face="Times New Roman">EXHIBIT INDEX</FONT></B></P>
<TABLE cellSpacing=0 cellPadding=0 width="100%" border=0>

<TR vAlign=bottom>
   <TD width="1%" noWrap align=left><B><FONT size=2 face="Times New Roman">Exhibit</FONT></B></TD>
   <TD width="1%" noWrap align=left>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</TD>
   <TD width="100%" noWrap align=left><B><FONT size=2 face="Times New Roman">Description</FONT></B></TD></TR>
<TR vAlign=bottom>
   <TD width="1%" noWrap align=left><A HREF="clorox3371771-ex991.htm" STYLE="-sec-extract: exhibit"><FONT size=2 face="Times New Roman">99.1</FONT></A></TD>
   <TD width="1%" noWrap align=left><FONT size=2 face="Times New Roman"></FONT></TD>
   <TD width="100%" noWrap align=left><A HREF="clorox3371771-ex991.htm" STYLE="-sec-extract: exhibit"><FONT size=2 face="Times New Roman">Press Release dated January 22, 2018, of The Clorox Company</FONT></A></TD></TR></TABLE>
<BR>
<HR align=center width="100%" noShade size="2">

<DIV style="PAGE-BREAK-BEFORE: always"></DIV>

<P STYLE="text-align: center">
<B><FONT size=2 face="Times New Roman">SIGNATURES</FONT></B></P>
<P style="text-align: left;">
<FONT size=2 face="Times New Roman">Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" BORDER="0" STYLE="line-height: 14pt; border-collapse: collapse; width: 100%">

  <TR vAlign=bottom>
    <TD NOWRAP STYLE="text-align: left"></TD>
    <TD NOWRAP STYLE="text-align: left"></TD>
    <TD NOWRAP STYLE="text-align: left">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</TD>
    <TD NOWRAP COLSPAN="2" STYLE="text-align: left"><FONT face="Times New Roman" size=2>THE CLOROX
      COMPANY</FONT></TD></TR>
  <TR>
    <TD COLSPAN="5">&nbsp;</TD></TR>
  <TR vAlign=bottom>
    <TD NOWRAP STYLE="text-align: left; width: 1%"><FONT face="Times New Roman" size=2>Date:&nbsp;&nbsp;</FONT></TD>
    <TD NOWRAP STYLE="text-align: left; width: 49%"><FONT face="Times New Roman" size=2>January 22, 2018 </FONT></TD>
    <TD NOWRAP STYLE="text-align: left; width: 1%"></TD>
    <TD NOWRAP STYLE="text-align: left; width: 1%"><FONT face="Times New Roman" size=2>By:&nbsp;&nbsp;</FONT></TD>
    <TD NOWRAP STYLE="border-bottom: #000000 1pt solid; text-align: left; width: 48%; padding-left: 4pt"><FONT face="Times New Roman" size=2>/s/ Laura Stein</FONT></TD></TR>
  <TR vAlign=bottom>
    <TD NOWRAP STYLE="text-align: left"></TD>
    <TD NOWRAP STYLE="text-align: left"></TD>
    <TD NOWRAP STYLE="text-align: left"></TD>
    <TD NOWRAP COLSPAN="2" STYLE="text-align: left"><FONT face="Times New Roman" size=2>Executive Vice President &#150;</FONT></TD></TR>
    <TR STYLE="vertical-align: bottom">
    <TD NOWRAP STYLE="text-align: left">&nbsp;</TD>
    <TD NOWRAP STYLE="text-align: left">&nbsp;</TD>
    <TD NOWRAP STYLE="text-align: left">&nbsp;</TD>
    <TD NOWRAP COLSPAN="2" STYLE="text-align: left"><FONT face="Times New Roman" size=2>General Counsel
      and Corporate Affairs</FONT></TD></TR>
</TABLE>
<BR>

<HR noshade align="center" width="100%">


</BODY>

</HTML>

</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>2
<FILENAME>clorox3371771-ex991.htm
<DESCRIPTION>PRESS RELEASE DATED JANUARY 22, 2018
<TEXT>

<HTML>
<HEAD>
   <TITLE></TITLE>
</HEAD>

<BODY bgcolor="#ffffff">


<TABLE style="LINE-HEIGHT: 14pt; BORDER-COLLAPSE: COLLAPSE" cellSpacing=0 cellPadding=0 width="100%" border=0>

<TR vAlign=bottom>
   <TD style="BORDER-BOTTOM: #000000 1pt solid" vAlign=top width="50%" noWrap align=left><FONT size=
2 face="Times New Roman">PRESS RELEASE</FONT></TD>
   <TD style="BORDER-BOTTOM: #000000 1pt solid" width="50%" noWrap align=right><FONT size=2 face=
"Times New Roman">
   <IMG border=0 src="clorox3371771-ex991x1x1.jpg"></FONT></TD></TR></TABLE>
<BR>
<P style="TEXT-ALIGN: left"><B><FONT size=2 face="Times New Roman">Clorox EVP
</FONT></B><B><FONT size=2 face="Times New Roman">&#8211; </FONT></B><B><FONT size=2 face=
"Times New Roman">CFO Steve Robb to Retire; Kevin Jacobsen Named SVP </FONT></B><B><FONT size=
2 face="Times New Roman">&#8211; </FONT></B><B><FONT size=2 face=
"Times New Roman">CFO</FONT></B></P>
<P style="TEXT-ALIGN: left"><B><FONT size=2 face="Times New Roman">OAKLAND, Calif., Jan. 22, 2018
&#8211; </FONT></B><FONT size=2 face="Times New Roman">The Clorox Company (NYSE:CLX) today
announced the following changes:</FONT></P>
<P style="TEXT-ALIGN: left"><FONT size=2 face="Times New Roman">Executive Vice President &#8211;
Chief Financial Officer </FONT><B><FONT size=2 face="Times New Roman">Stephen M.
&#8220;Steve&#8221; Robb </FONT></B><FONT size=2 face="Times New Roman">has announced his decision
to retire from the company. Robb, who joined Clorox in 1989, has been the company&#8217;s chief
financial officer since 2011 and a member of the company&#8217;s executive management committee,
with responsibility for leading all aspects of Clorox&#8217;s financial activities, including
accounting, reporting, internal controls, treasury, tax and investor relations. During his career
with Clorox, Robb has overseen the company&#8217;s cost savings efforts, which have produced an
average of $100 million in savings annually. During his tenure as CFO, Robb has helped the company
deliver a strong track record of financial results and total shareholder returns, in part enabled
by these cost savings. In 2017, he was selected by the San Francisco Business Times as the Bay Area
CFO of the Year for a large public company.</FONT></P>
<P style="TEXT-ALIGN: left"><FONT size=2 face="Times New Roman">&#8220;After 29 years with the
company, Steve leaves a tremendous legacy of financial stewardship and discipline that has served
the company and investors well and will contribute to the company for years to come,&#8221; said
Chairman and CEO Benno Dorer. &#8220;We are grateful for his many years of service to the company
and contributing greatly in his years as CFO. We thank him for his integrity, leadership and
distinguished service.</FONT></P>
<P style="TEXT-ALIGN: left"><FONT size=2 face="Times New Roman">"Steve will actively serve in his
CFO role through March 31, and then continue in an advisory capacity through the end of the fiscal
year,&#8221; Dorer continued. &#8220;Steve&#8217;s leadership, focus on total shareholder return
and the timing of this announcement will ensure a smooth and orderly transition that will help us
continue our focus on driving growth that is profitable, sustainable and responsible.&#8221;
</FONT></P>
<P style="TEXT-ALIGN: left"><FONT size=2 face="Times New Roman">Effective April 1,
</FONT><B><FONT size=2 face="Times New Roman">Kevin Jacobsen </FONT></B><FONT size=2 face=
"Times New Roman">will succeed Robb and has been appointed senior vice president &#8211; chief
financial officer and a member of the company&#8217;s executive management committee, reporting to
CEO Dorer. Jacobsen, who joined Clorox in 1995, has served as Clorox&#8217;s vice president &#8211;
Financial Planning &amp; Analysis since November 2011. During his tenure at Clorox, he has held
senior leadership roles in Finance across the company. In all of these assignments, Jacobsen has
focused on developing and implementing business strategies that drive increased shareholder value.
As CFO, Jacobsen will oversee all aspects of Clorox&#8217;s financial activities.</FONT></P>
<P style="TEXT-ALIGN: left"><FONT size=2 face="Times New Roman">"Kevin brings strong leadership,
insight and a deep understanding of Clorox&#8217;s financial model," Robb said. "He is the
company&#8217;s finance lead on our Business Operations Leadership Team and has helped to drive the
financial success we've achieved. I couldn&#8217;t be more pleased to be passing the baton to
Kevin." </FONT></P>

<P style="TEXT-ALIGN: left"><FONT size=2 face="Times New Roman">&#8220;Kevin&#8217;s appointment as CFO is a great example of our robust
succession-planning process,&#8221; said Dorer. &#8220;He is a seasoned and thoughtful executive
with more than 20 years of experience across the Clorox finance organization and brings deep
experience and strategic continuity to the CFO role.&#8221; </FONT></P>
<P style="TEXT-ALIGN: left"><FONT size=2 face="Times New Roman">Photos of and additional
biographical information on Robb and Jacobsen are available at </FONT><FONT size=2 face=
"Times New Roman">https://www.thecloroxcompany.com/who-we-are/corporate-governance/executive-team/</FONT></P>

<P style="TEXT-ALIGN: left"><B><FONT size=2 face="Times New Roman">The Clorox
Company</FONT></B></P>
<P style="TEXT-ALIGN: left"><FONT size=2 face="Times New Roman">The Clorox Company (NYSE:
</FONT><U><FONT size=2 face="Times New Roman">CLX</FONT></U><FONT size=2 face="Times New Roman">)
is a leading multinational manufacturer and marketer of consumer and professional products with
approximately 8,100 employees worldwide and fiscal year 2017 sales of $6 billion. Clorox markets
some of the most trusted and recognized consumer brand names, including its namesake bleach and
cleaning products; Pine-Sol<SUP>&#174; </SUP>cleaners; Liquid Plumr<SUP>&#174; </SUP>clog removers;
Poett<SUP>&#174; </SUP>home care products; Fresh Step<SUP>&#174; </SUP>cat litter; Glad<SUP>&#174;
</SUP>bags, wraps and containers; Kingsford<SUP>&#174; </SUP>charcoal; Hidden Valley<SUP>&#174;
</SUP>dressings and sauces; Brita<SUP>&#174; </SUP>water-filtration products; Burt's
Bees<SUP>&#174; </SUP>natural personal care products; and RenewLife<SUP>&#174; </SUP>digestive
health products. The company also markets brands for professional services, including Clorox
Healthcare&#174; and Clorox Commercial Solutions<SUP>&#174;</SUP>. More than 80 percent of the
company's sales are generated from brands that hold the No. 1 or No. 2 market share positions in
their categories. For more information, visit TheCloroxCompany.com, including the Good Growth blog,
and follow the company on Twitter at @CloroxCo.</FONT></P>
<P style="TEXT-ALIGN: left"><B><FONT size=2 face="Times New Roman">Media
Relations:<BR></FONT></B><FONT size=2 face="Times New Roman">Aileen Zerrudo 510-271-7892,
aileen.zerrudo@clorox.com or Kathryn Caulfield 510-271-7209,
kathryn.caulfield@clorox.com</FONT></P> <P style="text-align: left;">
<B><FONT size=2 face="Times New Roman">Investor Relations:</FONT></B></P>
<P style="text-align: left;">
<FONT size=2 face="Times New Roman">Joel Ramirez 510-271-3012, joel.ramirez@clorox.com; Lisah
Burhan 510-271-3269, lisah.burhan@clorox.com or Steve Austenfeld 510-271-2270,
steve.austenfeld@clorox.com</FONT></P>
<P style="TEXT-ALIGN: left"><FONT size=2 face="Times New Roman">Page 1 of 1</FONT></P>
<HR align=center width="100%" noShade size="2">


</BODY>

</HTML>

</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>3
<FILENAME>clorox3371771-ex991x1x1.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 clorox3371771-ex991x1x1.jpg
M_]C_X  02D9)1@ ! 0$ 70!=  #_[@ .061O8F4 9      !_]L 0P ! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$!_]L 0P$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!_\  $0@
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M;WZ&VD"RX4_<%?E%XD;_ (WA_!Y=W7_@E;^T.=N>H_X:R_9HR<>F0N?<#T%
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MGW3?#2X72M/EBTF2WOY(6U"7Z[T/Q'\>O#W_  6C_P""F-S\*/VH/V7/V?\
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M^G_")36NIW/PAU_XLZ7XT?3[KP== 2L-7OM.#^;LE /HS_@J3_P1B_X)S_\
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M[I6G:%H6C:;;QVNG:3HVD6<.GZ9IEA:Q!8K:RL+*W@M;6WC58X8(HXT 50*
M-6LAO#^@OKT/BE]$TA_$]MI-SH%OXC;3;-M>@T*\O+74+S18=7,)U"+2;J_L
M;*^N=.2X6SGO+.UN986FMXG37HH YAO!'@M]"U'PN_A'PPWAG5[S4=1U;PZV
M@:4VA:IJ&KZG+K>K7^HZ0;0Z?>WFJ:S//J^HW5S;RSWNIS2W]R\MW(\IXSQ7
M\ O@3X\UJY\2^./@K\)?&?B*]CMXKS7_ !7\./!WB+6KN*T@CM;6.YU75]&O
M+Z>.VM8HK:W26=UA@CCAC"QHJCUJB@# U3PIX7USPY<>#]:\-Z!K'A*[T^/2
M;KPMJFCZ=J'ARYTJ)$CBTRXT2[MIM,FT^..*...RDM6MD2-$6(*B@?@+_P %
M3_@#_P %(?A)\.M8\7_\$V? W['GQ,^!?A6RC\7ZY^QQXP_94\#:UXSLO$&E
MVES:ZCXE^$,&FVMAX;\=:E-I=Q<2Q^%]1TK2_&R ZC8>&]7\6W6K6'AVW_H9
MHH _S6OV9_\ @Y)^)W@OX@VOPM_X*!_L=_LU_%K]F_2-4U*UU_X5>!_V=/!?
MP[\:?#'QDM_&NH^)=!\)>)9)O"%WKEI+#=6OB#POK^F:!J-_<K"5\3Z)<64\
M5]_?/^S#^TI^Q_\ ML_ [P-\:?V?/%7PW^)/PJT!]/UO0=NFZ5:W?PHU_0=/
MN;:&SUCPMJMK!J/PQ\6^%["6]M$M[RQTB]L-.EDGTV631KV"[N?S]_X*T?\
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M$\"3>$O#,O@>+3+;1(_!LN@Z5)X4CT:R2**STA/#KVATA-,M(X(8[:P6S%I
MD,211(L: 59/A[X!FTCQ/X>E\#^#Y= \;7^I:KXST.3PSHKZ1XNU365A75]2
M\3Z:UD;+7[_55MX%U*\U6"[N+Y881=22B- O844 84OA;PQ./#HG\.:#,/"%
MQ'=^$Q+I&GR#PO=PZ9=:+%<^'0]NPT2XBT:]O=)CFTW[-(FF7=U8*PM;B6)]
MVBB@ HHHH **** "BBB@ K-OM&T?5+G1[W4]*TW4;SP]J,FL:!=WUC:W=SH>
MKRZ5J>A2ZIH\]Q%)+IFHRZ)K6L:/)?63P7+Z5JVIZ>TIM+^ZAE** -*BBB@
6HHHH **** "BBB@ HHHH **** /_V0$!

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
